Effect of ACE I/D polymorphism in cardiovascular disease patients

https://doi.org/10.53730/ijhs.v6nS3.8544

Authors

  • Maha Mashrq Al-Bayati Department of Biology, Faculty of Sciences, University of Kufa, Iraq
  • Alaa Shakir Al-Nahi Department of Biology, Faculty of Sciences, University of Kufa, Iraq

Keywords:

ACE, I/D, polymorphism, cardiovascular, patients

Abstract

Cardiovascular diseases (CVD) are the cause of the highest mortality rate among noncommunicable diseases, Some of the main risk factors for CVD include smoking, hypertension, high body mass index, lipid metabolism disorders, and diabetes mellitus, according to emerging evidence, Genetics and polymorphisms are thought to play an important role in the occurrence and progression of CVD. A number of 100 subjects were involved in this investigation, 70 of them with CVDs and the other 30 healthy individuals were used as control. The study was conducted to find out the importance of ACE gene polymorphism and biochemical variables in CVDs patients. In addition, the study aimed to investigate the effect of gene polymorphism on CVDs. The comparisons between genotypic frequency of ACE gene polymorphism in control and CVDs  patients  showed a significant increase (p≤0.005) in DD, ID  genotype   in CVDs  patients compared to control , where II genotype significant decreased in CVDs patients compared to control. Our results show insertion mutation at 550bp only in CVDs patients, this mutation not show in other research.

Downloads

Download data is not yet available.

References

World Health Organization. Noncommunicable Diseases. Available online: https://www.who.int/news-room/fact-sheets/detail/noncommunicable-diseases (accessed on 19 April 2021).

Iriti, M.; Varoni, E.M.; Vitalini, S. Healthy Diets and Modifiable Risk Factors for Non-Communicable Diseases—The European Perspective. Foods 2020, 9, 940. [CrossRef] [PubMed]

Gbadamosi, M.A.; Tlou, B. Modifiable risk factors associated with non-communicable diseases among adult outpatients in Manzini, Swaziland: A cross-sectional study. BMC Public Health 2020, 20, 665. [CrossRef] [PubMed]

Zhai, C., Cong, H., Zhang, H., Hou, K., Zhang, Y., & Zhang, Y. (2019). M235T polymorphism in the angiotensinogen gene and cardiovascular disease: An updated meta-analysis of 39 case–control comparisons. Anatolian Journal of Cardiology, 21(4), 222.

Amara, A., Mrad, M., Sayeh, A., Lahideb, D., Layouni, S., Haggui, A., ... & Nsiri, B. (2018). The effect of ACE I/D polymorphisms alone and with concomitant risk factors on coronary artery disease. Clinical and Applied Thrombosis/Hemostasis, 24(1), 157-163.‏

Ahmad Yusof, H., & Che Muhamed, A. M. (2021). Angiotensin-converting enzyme (ACE) insertion/deletion gene polymorphism across ethnicity: a narrative review of performance gene. Sport Sciences for Health, 17(1), 57-77.‏

Nehme, A., Zouein, F. A., Deris Zayeri, Z., & Zibara, K. (2019). An update on the tissue renin angiotensin system and its role in physiology and pathology. Journal of cardiovascular development and disease, 6(2), 14.

Phillips, M. I., Speakman, E. A., & Kimura, B. (2018). Tissue renin-angiotensin systems. In Cellular and Molecular Biology of the renin-angiotensin system (pp. 97-130). CRC Press.‏

Dos Santos, J. H. B., Passos, R. S., Freire, I. V., Ribeiro, I. J., Oliveira, A. A., Casotti, C. A., ... & Pereira, R. (2021). The D allele of angiotensin-converting enzyme gene is associated with a worse autonomic heart control in community-based older adults. Experimental Gerontology, 146, 111227.‏

Duque, G. S., Silva, D. A. D., Albuquerque, F. N. D., Schneider, R. S., Gimenez, A., Pozzan, R., ... & Albuquerque, D. C. D. (2016). Influence of angiotensin-converting-enzyme gene polymorphism on echocardiographic data of patients with ischemic heart failure. Arquivos Brasileiros de Cardiologia, 107, 446-454.‏

Malakar, A. K., Choudhury, D., Halder, B., Paul, P., Uddin, A., & Chakraborty, S. (2019). A review on coronary artery disease, its risk factors, and therapeutics. Journal of cellular physiology, 234(10), 16812-16823.‏

Shafiee, S. M., Firoozrai, M., Salimi, S., Zand, H., Hesabi, B., & Mohebbi, A. (2010). Angiotensin converting enzyme DD genotype not associated with increased risk of coronary artery disease in the Iranian population. Pathophysiology, 17(3), 163-167.‏

Kato, N., Tatara, Y., Ohishi, M., Takeya, Y., Onishi, M., Maekawa, Y., & Rakugi, H. (2011). Angiotensin-converting enzyme single nucleotide polymorphism is a genetic risk factor for cardiovascular disease: a cohort study of hypertensive patients. Hypertension Research, 34(6), 728-734.‏

Al-Nahi, A. S., & Al-Barqaawee, M. J. (2019). ACE gene Polymorphism on Diabetic Type 2 Patients and their Susceptibility to Diabetic Nephropathy. Indian Journal of Public Health Research & Development, 10(10).

Published

07-06-2022

How to Cite

Al-Bayati, M. M., & Al-Nahi, A. S. (2022). Effect of ACE I/D polymorphism in cardiovascular disease patients. International Journal of Health Sciences, 6(S3), 9671–9676. https://doi.org/10.53730/ijhs.v6nS3.8544

Issue

Section

Peer Review Articles